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Meningiomas are classified into 4 groups according to
the recent “World Health Organization (WHO)“
classification system: typical meningioma, atypical
meningioma, papillary meningioma and anaplastic
(malignant) meningioma (1-4). Secretory meningioma,
which is a subtype of typical meningiomas, constitutes
approximately 3% of all meningiomas. The disease is
encountered predominantly in elderly females with a ratio
of 9/1 (5).
Clinically, the preoperative computed tomography or
magnetic resonance imaging scans show evident
peritumoral edema. The main histologic feature is the
hyaline inclusions formed as a result of the epithelial
differentiation of the meningothelial cells (5). In this
report, a 65-year-old woman diagnosed with secretory
meningioma is presented, both because of the tumor’s
rarity and its distinctive histopathologic and
immunohistochemical features.

Case Report
A 65 year-old woman (NA, 12285/99) presented with
an 8-month history of headache, starting at the right side
of her head and gradually spreading throughout.
Computerized tomography disclosed a mass at the lateral
side of the right sphenoid wing and the mass was excised
totally.
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On gross examination, the material consisted of
hyperemic, tan to white colored tissues of 1.5x1.3x0.8
cm to 3x2x2 mm.
Histologic examination revealed round or oval tumor
cells with vesiculated nuclei and eosinophilic cytoplasms.
While some of the tumor cells were arranged in a
storiform pattern, others formed lumens. With the
hematoxylen-eosine stained sections, there was a
prominent homogenous, eosinophilic material in these
lumens (Fig. 1). Histochemically, periodic acid-Schiff
(PAS) and elastica van Gieson (EVG) stains were applied
to the paraffin embedded tissues, and the secretory
globules stained red with PAS and orange with EVG (Figs.
2-3). The immunohistochemical study revealed
cytokeratin (Fig. 4), carcinoembryonic antigen (CEA)
(Fig. 5) and epithelial membrane antigen (EMA) (Fig. 6)
positivity in the secretory globules. With these findings
the diagnosis was thought to be “typical meningioma
(secretory type)”.
Secretory meningioma is a rare neoplasm, which is
described as a new variant of meningiomas according to
the WHO classification of brain tumors in 1993 (2). Most
of the tumors are localized at the sphenoid or the frontal
regions and the first symptom of the patients is usually
either headaches or convulsions (1,5). The scanning
methods reveal some distinct features of secretory
meningioma which distinguish it from the other subtypes
of meningioma. The most distinctive feature is its strong
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Fig 1.

The adenoid structures formed by the tumor cells in this
secretory meningioma case and the eosinophilic secretion
in the lumen (H+E, x200).

Fig 2.

The secretion in the lumens of the adenoid structures
stained red with the PAS reaction (x200).

Fig 3.

The secretion in the lumens of the adenoid structures
stained orange with EVG (x200).

Fig 4.

The secretion in the lumens of the adenoid structures
stained positively with cytokeratin (x200).

Fig 5.

The secretion in the lumens of the adenoid structures
stained positively with CEA (x200).

Fig 6.

The secretion in the lumens of the adenoid structures
stained positively with EMA (x200).
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tendency to develop brain edema (5-7). Brain edema is a
finding which usually accompanies malignant, aggressive
and rapidly growing intraparenchymatous tumors. Since
secretory meningioma is a benign, slowly developing
tumor, its association with brain edema seems to be
conflicting. However, as a result of some hypotheses
which have been proposed to explain this association, it
was thought to be multifactorial (5).
Microscopically, secretory meningiomas reveal a
meningothelial growth pattern, and the presence of
moderate to abundant secretory globules of different
sizes is a characteristic feature (5). The first descriptive
term for these characteristic structures was introduced
by Cushing and Eisenhardt as “glassy hyaline inclusions”
(HI) (5,8). Following a publication by Kepes in 1961,
these inclusions were also referred to as
“pseudopsammoma bodies” (5,9). Since 1986, after the
unique secretory features of these meningiomas were
established, the term “secretory meningioma,” proposed
by Alguacil Garcia et al., (5,10) has been used.
Histochemical, immunocytochemical and ultrastructural
studies have revealed that pseudopsammoma bodies in
meningiomas are identical with intracytoplasmic
inclusions of some epithelial neoplasms, especially of
mammary and gastric carcinomas (11). Ultrastructurally
these inclusions are characterized by granular, proteinous
material localized in either the intracytoplasmic or the
extracytoplasmic lumens surrounded by microvilli (12).
In a study by Sav et al. including 6 secretory
meningioma patients, the most useful histochemical

stains in determining the inclusions were found to be PAS
and EVG (12). The inclusions were PAS positive, diastase
resistant and stain picrofylic (yellow-orange) with EVG.
On the other hand, von Kossa, Congo red and Gomori’s
reticulin have revealed negative staining (3,4,12). We
achieved similar results with PAS and EVG in our patient
(Figs. 2,3). The inclusions and the surrounding
cytoplasms stain positively with cytokeratin, CEA, EMA,
Alpha 1-antitrypsin, Alpha 1-antichymotrypsin and
Immunoglobulins (5). On the other hand, tumor cells
which lack inclusions have prominent vimentin positivity,
while S-100 protein is only locally reactive. We applied
cytokeratin, CEA and EMA and achieved distinct positivity
(Figs. 4-6).
P53 immunoreactivity and micronecrosis are helpful
findings in determining the probability of recurrences in
meningiomas (13). It is also confirmed that the
recurrences in patients receiving radiotherapy are fewer
(13). Our patient, who had surgical excision as the only
treatment, did not have a recurrence during the 10
month period.
In conclusion, since secretory meningioma is a rare
variant of meningiomas and has a distinct histopathologic
appearance in addition to its benignity, and although it
has prominent peritumoral edema determined by the
scanning techniques, it should be kept in mind and
distinguished mainly from the other subtypes of
meningiomas.
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